Literature DB >> 1056036

Kinetics of opiate receptor inactivation by sulfhydryl reagents: evidence for conformational change in presence of sodium ions.

E J Simon, J Groth.   

Abstract

The role of SH groups in opiate-receptor interactions has been further examined. In activation by N-ethylmaleimide of sterospecific opiate binding by rat brain membrane fractions follows pseudo-first order kinetics and exhibits strong temperature dependence. The kinetics indicate that alkylation of a single SH group suffices to block opiate binding. Considerable protection from SH group inactivation is observed when treatment with N-ethylmaleimide is carried out in the presence of an opiate or an antagonist, suggesting close proximity of the SH group to the opiate binding site. The rate of inactivation of receptor binding by N-ethylmaleimide is markedly slower in buffers containing 100 mM NaCl (t1/2 equals 30 plus or minus 1.4 min) than in sodium-free buffers (t1/2 equals 10 plus or minus 1.0 min). Since the rate of alkylation of model SH compounds is unaffected by sodium ions, this protection seems best explained by a conformational change in the receptors that renders the SH groups less accessible to alkylation. The rate of inactivation is not affected by K+, Rb+, or Cs+ and only slightly by Li+. This cation specificity as well as the concentration-response to Na+ are remarkably similar to those previously shown to lead to increased antagonist and decreased agonist binding. We suggest that the same conformational change is involved in the two phenomena.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1056036      PMCID: PMC432767          DOI: 10.1073/pnas.72.6.2404

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  10 in total

1.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

2.  Further properties of stereospecific opiate binding sites in rat brain: on the nature of the sodium effect.

Authors:  E J Simon; J M Hiller; J Groth; I Edelman
Journal:  J Pharmacol Exp Ther       Date:  1975-03       Impact factor: 4.030

3.  Opiate agonists and antagonists discriminated by receptor binding in brain.

Authors:  C B Pert; G Pasternak; S H Snyder
Journal:  Science       Date:  1973-12-28       Impact factor: 47.728

4.  Reduction of biological substances by water-soluble phosphines: gamma-globulin (IgG).

Authors:  M E Levison; A S Josephson; D M Kirschenbaum
Journal:  Experientia       Date:  1969-02-15

5.  Stereospecific interaction between narcotic analgesics and a synaptic plasm a membrane fraction of rat cerebral cortex.

Authors:  L Terenius
Journal:  Acta Pharmacol Toxicol (Copenh)       Date:  1973

6.  Interaction of sugars with the membrane protein component of the lactose transport system of Escherichia coli.

Authors:  J R Carter; C F Fox; E P Kennedy
Journal:  Proc Natl Acad Sci U S A       Date:  1968-06       Impact factor: 11.205

7.  Opiate receptor: demonstration in nervous tissue.

Authors:  C B Pert; S H Snyder
Journal:  Science       Date:  1973-03-09       Impact factor: 47.728

8.  Distribution of stereospecific binding of the potent narcotic analgesic etorphine in the human brain: predominance in the limbic system.

Authors:  J M Hiller; J Pearson; E J Simon
Journal:  Res Commun Chem Pathol Pharmacol       Date:  1973-11

9.  Stereospecific binding of the potent narcotic analgesic (3H) Etorphine to rat-brain homogenate.

Authors:  E J Simon; J M Hiller; I Edelman
Journal:  Proc Natl Acad Sci U S A       Date:  1973-07       Impact factor: 11.205

10.  Stereospecific and nonspecific interactions of the morphine congener levorphanol in subcellular fractions of mouse brain.

Authors:  A Goldstein; L I Lowney; B K Pal
Journal:  Proc Natl Acad Sci U S A       Date:  1971-08       Impact factor: 11.205

  10 in total
  23 in total

1.  Copper complexes of non-steroidal antiinflammatory agents: analgesic activity and possible opioid receptor activation.

Authors:  S Okuyama; S Hashimoto; H Aihara; W M Willingham; J R Sorenson
Journal:  Agents Actions       Date:  1987-06

2.  The opiate receptors.

Authors:  E J Simon
Journal:  Neurochem Res       Date:  1976-02       Impact factor: 3.996

3.  Coupling of opiate receptors to adenylate cyclase: requirement for Na+ and GTP.

Authors:  A J Blume; D Lichtshtein; G Boone
Journal:  Proc Natl Acad Sci U S A       Date:  1979-11       Impact factor: 11.205

Review 4.  The regulation of AMPA receptor-binding sites.

Authors:  K K Dev; J M Henley
Journal:  Mol Neurobiol       Date:  1998       Impact factor: 5.590

5.  Inactivation of the purified bovine mu opioid receptor by sulfhydryl reagents.

Authors:  T L Gioannini; I Onoprishvili; J M Hiller; E J Simon
Journal:  Neurochem Res       Date:  1999-01       Impact factor: 3.996

6.  Disruption of the Na+ ion binding site as a mechanism for positive allosteric modulation of the mu-opioid receptor.

Authors:  Kathryn E Livingston; John R Traynor
Journal:  Proc Natl Acad Sci U S A       Date:  2014-12-08       Impact factor: 11.205

Review 7.  Allostery at opioid receptors: modulation with small molecule ligands.

Authors:  Kathryn E Livingston; John R Traynor
Journal:  Br J Pharmacol       Date:  2017-06-07       Impact factor: 8.739

Review 8.  Dynorphin--still an extraordinarily potent opioid peptide.

Authors:  Charles Chavkin
Journal:  Mol Pharmacol       Date:  2012-11-14       Impact factor: 4.436

9.  Multiple opiate receptors: [3H]ethylketocyclazocine receptor binding and ketocyclazocine analgesia.

Authors:  G W Pasternak
Journal:  Proc Natl Acad Sci U S A       Date:  1980-06       Impact factor: 11.205

10.  mu opiate receptor: cDNA cloning and expression.

Authors:  J B Wang; Y Imai; C M Eppler; P Gregor; C E Spivak; G R Uhl
Journal:  Proc Natl Acad Sci U S A       Date:  1993-11-01       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.